368 related articles for article (PubMed ID: 28129109)
21. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
Shan X; Vocadlo D; Krieger C
Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
[TBL] [Abstract][Full Text] [Related]
22. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43.
Stribl C; Samara A; Trümbach D; Peis R; Neumann M; Fuchs H; Gailus-Durner V; Hrabě de Angelis M; Rathkolb B; Wolf E; Beckers J; Horsch M; Neff F; Kremmer E; Koob S; Reichert AS; Hans W; Rozman J; Klingenspor M; Aichler M; Walch AK; Becker L; Klopstock T; Glasl L; Hölter SM; Wurst W; Floss T
J Biol Chem; 2014 Apr; 289(15):10769-10784. PubMed ID: 24515116
[TBL] [Abstract][Full Text] [Related]
24. Protein Disulfide Isomerase Endoplasmic Reticulum Protein 57 (ERp57) is Protective Against ALS-Associated Mutant TDP-43 in Neuronal Cells.
Parakh S; Perri ER; Vidal M; Takalloo Z; Jagaraj CJ; Mehta P; Yang S; Thomas CJ; Blair IP; Hong Y; Atkin JD
Neuromolecular Med; 2024 Jun; 26(1):23. PubMed ID: 38861223
[TBL] [Abstract][Full Text] [Related]
25. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
26. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain.
Wang G; Yang H; Yan S; Wang CE; Liu X; Zhao B; Ouyang Z; Yin P; Liu Z; Zhao Y; Liu T; Fan N; Guo L; Li S; Li XJ; Lai L
Mol Neurodegener; 2015 Sep; 10():42. PubMed ID: 26334913
[TBL] [Abstract][Full Text] [Related]
27. Dysregulated Expression of Transposable Elements in TDP-43
Valdebenito-Maturana B; Rojas-Tapia MI; Carrasco M; Tapia JC
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555863
[TBL] [Abstract][Full Text] [Related]
28. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD.
White MA; Kim E; Duffy A; Adalbert R; Phillips BU; Peters OM; Stephenson J; Yang S; Massenzio F; Lin Z; Andrews S; Segonds-Pichon A; Metterville J; Saksida LM; Mead R; Ribchester RR; Barhomi Y; Serre T; Coleman MP; Fallon JR; Bussey TJ; Brown RH; Sreedharan J
Nat Neurosci; 2018 Apr; 21(4):552-563. PubMed ID: 29556029
[TBL] [Abstract][Full Text] [Related]
29. Temporal Expression of Mutant TDP-43 Correlates with Early Amyotrophic Lateral Sclerosis Phenotype and Motor Weakness.
Chen Q; Zhou J; Huang C; Huang B; Bi F; Zhou H; Xiao B
Curr Neurovasc Res; 2018; 15(1):3-9. PubMed ID: 29313467
[TBL] [Abstract][Full Text] [Related]
30. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice.
Xu YF; Gendron TF; Zhang YJ; Lin WL; D'Alton S; Sheng H; Casey MC; Tong J; Knight J; Yu X; Rademakers R; Boylan K; Hutton M; McGowan E; Dickson DW; Lewis J; Petrucelli L
J Neurosci; 2010 Aug; 30(32):10851-9. PubMed ID: 20702714
[TBL] [Abstract][Full Text] [Related]
31. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43.
Arnold ES; Ling SC; Huelga SC; Lagier-Tourenne C; Polymenidou M; Ditsworth D; Kordasiewicz HB; McAlonis-Downes M; Platoshyn O; Parone PA; Da Cruz S; Clutario KM; Swing D; Tessarollo L; Marsala M; Shaw CE; Yeo GW; Cleveland DW
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):E736-45. PubMed ID: 23382207
[TBL] [Abstract][Full Text] [Related]
32. Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43.
Caccamo A; Shaw DM; Guarino F; Messina A; Walker AW; Oddo S
Hum Mol Genet; 2015 Aug; 24(16):4625-35. PubMed ID: 26002100
[TBL] [Abstract][Full Text] [Related]
33. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
Vanden Broeck L; Callaerts P; Dermaut B
Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
[TBL] [Abstract][Full Text] [Related]
34. PABPN1 suppresses TDP-43 toxicity in ALS disease models.
Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W
Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692
[TBL] [Abstract][Full Text] [Related]
35. TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43.
Godoy-Corchuelo JM; Ali Z; Brito Armas JM; Martins-Bach AB; García-Toledo I; Fernández-Beltrán LC; López-Carbonero JI; Bascuñana P; Spring S; Jimenez-Coca I; Muñoz de Bustillo Alfaro RA; Sánchez-Barrena MJ; Nair RR; Nieman BJ; Lerch JP; Miller KL; Ozdinler HP; Fisher EMC; Cunningham TJ; Acevedo-Arozena A; Corrochano S
Neurobiol Dis; 2024 Apr; 193():106437. PubMed ID: 38367882
[TBL] [Abstract][Full Text] [Related]
36. Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits.
Ho WY; Agrawal I; Tyan SH; Sanford E; Chang WT; Lim K; Ong J; Tan BSY; Moe AAK; Yu R; Wong P; Tucker-Kellogg G; Koo E; Chuang KH; Ling SC
Acta Neuropathol Commun; 2021 Jan; 9(1):9. PubMed ID: 33407930
[TBL] [Abstract][Full Text] [Related]
37. Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.
Ke YD; van Hummel A; Au C; Chan G; Lee WS; van der Hoven J; Przybyla M; Deng Y; Sabale M; Morey N; Bertz J; Feiten A; Ippati S; Stevens CH; Yang S; Gladbach A; Haass NK; Kril JJ; Blair IP; Delerue F; Ittner LM
Neuron; 2024 Apr; 112(8):1249-1264.e8. PubMed ID: 38366598
[TBL] [Abstract][Full Text] [Related]
38. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons.
Wang W; Li L; Lin WL; Dickson DW; Petrucelli L; Zhang T; Wang X
Hum Mol Genet; 2013 Dec; 22(23):4706-19. PubMed ID: 23827948
[TBL] [Abstract][Full Text] [Related]
39. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations.
Le NT; Chang L; Kovlyagina I; Georgiou P; Safren N; Braunstein KE; Kvarta MD; Van Dyke AM; LeGates TA; Philips T; Morrison BM; Thompson SM; Puche AC; Gould TD; Rothstein JD; Wong PC; Monteiro MJ
Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7580-E7589. PubMed ID: 27834214
[TBL] [Abstract][Full Text] [Related]
40. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
